AI assistant
EMV CAPITAL PLC — Director's Dealing 2015
Nov 10, 2015
7623_dirs_2015-11-10_0640ea52-2d6e-490d-9b9c-d2f79d7d4d76.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 1137F
NetScientific PLC
10 November 2015
NetScientific PLC
("NetScientific" or the "Group")
Grant of Options to Director
London, UK - 10 November 2015: NetScientific plc (AIM:NSCI), a transatlantic biomedical healthcare group, announces that on 9 November 2015, options over a total of 359,020 Ordinary Shares of 5p each were granted to Francois Martelet.
| Director | Position | Number of Options Granted |
Number of Options Held |
| Francois Martelet | CEO | 359,020 | 359,020 |
The options have an exercise price of 119.5 pence per share and vest on the 8 June 2018, being the third anniversary of Francois Martelet's appointment as CEO.
- Ends -
For further information, please contact:
Contact Details
| NetScientific plc | Tel: +44 (0)20 3514 1800 | ||
| François Martelet, CEO | |||
| Peter Thoms, CFO | |||
| Investec Bank plc (NOMAD & Broker) Gary Clarence Daniel Adams |
Tel: +44 (0)20 7597 4000 | ||
| Instinctif Partners Melanie Toyne-Sewell Jayne Crook Rosanna Forrest |
Tel: +44 (0)20 7457 2020 [email protected] |
||
About NetScientific
NetScientific is a transatlantic biomedical and healthcare technology group with a differentiated investment strategy focused solely on digital health, diagnostics and therapeutics. The Group's objective is to source, fund and commercialise companies that significantly improve the lives of people with chronic diseases.
For more information, please visit the website at www.netscientific.net.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSFSIEFUFISESF